All In Biotech

Free tool

FAERS Monitor: Finacea

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021470 or its brand name (Finacea, Azelaic Acid). Reports on generic versions are filed under their own applications.

Reports

841

Serious

445

53% of reports

Hospitalization

168

Death reported

84

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective154
  • pain131
  • off label use118
  • abdominal pain upper110
  • vomiting110
  • product use in unapproved indication103
  • gastrooesophageal reflux disease102
  • paraesthesia102
  • migraine101
  • memory impairment99
  • hypoaesthesia98
  • rash96
  • blepharospasm95
  • taste disorder93
  • drug intolerance91

Reports by year received

View as table
YearReports
20042
20051
20061
20085
20093
20108
20112
20122
20133
20146
201520
201617
201712
201823
201931
202060
202167
202270
202385
2024134
2025139
2026150

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,318 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blepharospasmSignal95383.0316.435,282
taste disorderSignal93115.295.010,374
gastrooesophageal reflux diseaseSignal10231.726.43,012
migraineSignal10126.522.12,460
drug intoleranceSignal9123.619.41,952
memory impairmentSignal9918.015.01,585
hypoaesthesiaSignal9816.413.61,409
paraesthesiaSignal10216.213.51,452
abdominal pain upperSignal11013.411.21,258
product use in unapproved indicationSignal10310.48.7875
vomitingSignal1105.94.9448
rashSignal965.54.6357
painSignal1315.34.6471
off label useSignal1183.42.9203
drug ineffectiveSignal1542.92.5206

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.